Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Ref-1/APE1 inhibition with novel small molecules blocks ocular neovascularization.

Sardar Pasha SPB, Sishtla K, Sulaiman RS, Park B, Shetty T, Shah F, Fishel ML, Wikel JH, Kelley MR, Corson TW.

J Pharmacol Exp Ther. 2018 Aug 3. pii: jpet.118.248088. doi: 10.1124/jpet.118.248088. [Epub ahead of print]

2.

Antiangiogenic Activity and Cytotoxicity of Triterpenoids and Homoisoflavonoids from Massonia pustulata and Massonia bifolia.

Schwikkard SL, Whitmore H, Corson TW, Sishtla K, Langat MK, Carew M, Mulholland DA.

Planta Med. 2018 Jul;84(9-10):638-644. doi: 10.1055/a-0577-5322. Epub 2018 Feb 28.

PMID:
29490386
3.

Ferrochelatase is a therapeutic target for ocular neovascularization.

Basavarajappa HD, Sulaiman RS, Qi X, Shetty T, Sheik Pran Babu S, Sishtla KL, Lee B, Quigley J, Alkhairy S, Briggs CM, Gupta K, Tang B, Shadmand M, Grant MB, Boulton ME, Seo SY, Corson TW.

EMBO Mol Med. 2017 Jun;9(6):786-801. doi: 10.15252/emmm.201606561.

4.

Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids.

Lee B, Sun W, Lee H, Basavarajappa H, Sulaiman RS, Sishtla K, Fei X, Corson TW, Seo SY.

Bioorg Med Chem Lett. 2016 Sep 1;26(17):4277-81. doi: 10.1016/j.bmcl.2016.07.043. Epub 2016 Jul 21.

5.

Kif14 overexpression accelerates murine retinoblastoma development.

O'Hare M, Shadmand M, Sulaiman RS, Sishtla K, Sakisaka T, Corson TW.

Int J Cancer. 2016 Oct 15;139(8):1752-8. doi: 10.1002/ijc.30221. Epub 2016 Jun 24.

6.

Mapping protease substrates by using a biotinylated phage substrate library.

Scholle MD, Kriplani U, Pabon A, Sishtla K, Glucksman MJ, Kay BK.

Chembiochem. 2006 May;7(5):834-8.

PMID:
16628754

Supplemental Content

Loading ...
Support Center